Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Cell Therapy Market?

In recent times, the cell therapy market has experienced significant expansion. The market is projected to increase from a value of $14.56 billion in 2024 to $16.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. The historical development of the market can be traced back to initial research as well as breakthroughs, regulatory landmarks, clinical trials and investigations, early adopting companies, as well as the overall market receptivity and impression.

The market size for cell therapy is projected to experience swift expansion in the subsequent years, with a prediction to rise to “$28.67 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 14.2%. The escalation predicted within this forecast period can be accredited to ethics and societal aspects, investor and funding trends, customer/patient demand, healthcare facility structure, quick innovation cycles. The core trends anticipated during this period encompass personalized medicine, the advent of targeted treatments, gene alteration technologies, stem cell research broadening, advancements in immunotherapy, and the manipulation of microenvironments.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Cell Therapy Market?

The escalating incidence of chronic illnesses has prompted the growth of the cell therapy market. As defined by the US Centers for Disease Control and Prevention (CDC), a chronic disease is a health condition that persists for a year or longer, requires medical intervention, restricts daily tasks, or both. This category includes ailments like heart disease, cancer, diabetes, and Parkinson’s disease. Individuals afflicted with conditions like spinal cord injuries, type 1 diabetes, Parkinson’s disease, heart disease, cancer, and osteoarthritis can derive benefits from stem cells. For instance, the US Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, released significant updates on public health initiatives in July 2024. Each year, heart disease or stroke claims the lives of over 944,800 Americans, constituting more than one-third of total deaths. In the United States, cancer is diagnosed in 1.7 million individuals annually with over 600,000 resulting in death, making it the second most common cause of death. Moreover, diabetes affects over 38 million Americans, with another 98 million adults identified as prediabetic, increasing their chances of developing type 2 diabetes. Complications from diabetes can result in serious health problems like heart disease, kidney failure, and even blindness. Obesity, which afflicts 20% of children and 42% of adults, augments risk for chronic diseases such as type 2 diabetes, heart disease, and certain types of cancer. This heightened incidence of chronic illnesses has bolstered demand for cell therapies, thereby facilitating the expansion of the cell therapy market.

Which Segmentation Categories Are Highlighted In The Cell Therapy Market Analysis?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Which Market Trends Are Expected To Define The Future Of The Cell Therapy Market?

Major market participants are tactically forming partnerships and collaborations to enhance their range of products and extend their presence globally. In November 2023, Ajinomoto Co Inc., a food company originating from Japan, bought Forge Biologics for a sum of $620 million. With this purchase, Ajinomoto Co Inc. seeks to strengthen its worldwide efficacy in AAV and plasmid gene therapy production, supplementing and strengthening its currently available contract development and manufacturing services. Forge Biologics is a biotechnology firm situated in the U.S., dedicated to the progress of cell therapy technologies for treating a variety of diseases.

Who Are The Dominant Players In The Cell Therapy Market Today?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model